Search results
IGM Biosciences, Inc. (NASDAQ:IGMS) CEO Fred Schwarzer Sells 4,164 Shares of Stock
ETF DAILY NEWS· 5 days agoIGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) CEO Fred Schwarzer sold 4,164 shares of the business’s stock in a transaction that occurred on Friday, June 14th. The shares were sold at ...
Nektar Therapeutics (NASDAQ:NKTR) Share Price Crosses Above Two Hundred Day Moving Average of $0.98
ETF DAILY NEWS· 2 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.98 and traded as high ...
The Importance of Knowing Your Farmer
Mercola· 4 days agoLast year the Weston A. Price Foundation launched its 50% Campaign, urging consumers to purchase at least 50% of their food directly from farmers and artisan processors. This helps build a local ...
Research Analysts Set Expectations for argenx SE’s Q2 2025 Earnings (NASDAQ:ARGX)
ETF DAILY NEWS· 6 days agoargenx SE (NASDAQ:ARGX – Free Report) – Equities research analysts at Wedbush lowered their Q2 2025 earnings per share (EPS) estimates for argenx in a research note issued to investors on Monday ...
Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Guggenheim
ETF DAILY NEWS· 6 days agoGuggenheim assumed coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $100.00 target price ...
Cartesian Therapeutics (NASDAQ:RNAC) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 6 days agoHC Wainwright reiterated their buy rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $54.00 ...